Cover Image
市場調查報告書

醫療分析實驗服務的全球市場預測 2021年:穩定性實驗、原料實驗、分析法驗證、微生物實驗、環境監測、生物學的分析服務

Healthcare Analytical Testing Services Market by Type (Stability, Raw Materials, Method Validation, Microbial, Environmental Monitoring, Bioanalytical Services), by End User (Pharmaceutical Companies, Medical Device Companies) - Global Forecast to 2021

出版商 MarketsandMarkets 商品編碼 359267
出版日期 內容資訊 英文 346 Pages
訂單完成後即時交付
價格
Back to Top
醫療分析實驗服務的全球市場預測 2021年:穩定性實驗、原料實驗、分析法驗證、微生物實驗、環境監測、生物學的分析服務 Healthcare Analytical Testing Services Market by Type (Stability, Raw Materials, Method Validation, Microbial, Environmental Monitoring, Bioanalytical Services), by End User (Pharmaceutical Companies, Medical Device Companies) - Global Forecast to 2021
出版日期: 2016年05月30日 內容資訊: 英文 346 Pages
簡介

全球醫療分析實驗服務市場規模,預計從2016年到2021年以11.3%的年複合成長率發展,從2016年的24億2,000萬美元到2021年達到41億3,000萬美元。該市場的成長主要起因於生技藥品、大分子藥物分析服務的需求擴大,製藥公司的分析實驗外包的增加,來自營養補充品產業的需求高漲,及製藥研究/製造的QbD (品質源於設計) 方法的採用增加等。再加上製藥產業的高質量標準,生技仿製藥、生技藥品市場急速成長,及分析實驗供應商的豐富資金的存在,也更加推動醫療分析實驗服務市場成長。可是,市場參與企業所面臨的價格壓力及醫療分析實驗服務業高專業工作人力資源的不足,在預測期間內有妨礙該市場成長的可能性。

本報告以醫療分析實驗服務的全球市場為焦點,提供各種類、樣品、終端用戶及各地區交易規模的變化預測,市場現狀,發展的影響要素,競爭環境,主要企業等相關的調查、分析資訊彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 醫療分析實驗服務市場:概要
  • 亞太地區的醫療分析實驗服務市場:各終端用戶
  • 醫療分析實驗服務市場:地區概要
  • 醫療分析實驗服務市場:地區混合
  • 醫療分析實驗服務市場:新興 vs. 先進各國

第5章 市場概要

  • 簡介
  • 市場區隔
    • 各類型
    • 各終端用戶
    • 各樣品
  • 市場動態
  • 主要的推動市場的要素
  • 主要市場抑制因素
  • 主要市場機會
  • 主要課題

第6章 產業考察

  • 產業趨勢
  • 法規分析

第7章 醫療分析實驗服務市場:各類型

  • 簡介
  • 生物學的分析實驗
  • 物理的特性評估服務
  • 分析法驗證
  • 原料實驗
  • 順利地租賃實驗服務
  • 穩定性實驗
  • 微生物實驗
  • 環境監測

第8章 醫療分析實驗服務市場:各樣品

  • 簡介
  • 原料
  • 最後生成物
  • 界內流程樣品
  • 環境樣品

第9章 全球醫療分析實驗服務市場:各終端用戶

  • 簡介
  • 醫藥品、生物醫藥品企業
  • 醫療設備企業
  • CRO (醫藥品臨床研究委外機構)

第10章 醫療分析實驗服務市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他的歐洲 (ROE)
  • 亞太地區 (APAC)
    • 中國
    • 日本
    • 印度
    • 其他APAC
  • 其他 (ROW)
    • 南美
    • 中東、非洲

第11章 競爭情形

  • 簡介
  • 市場佔有率分析
  • 競爭情形、趨勢

第12章 企業簡介 (產業概要、產品 & 服務、發展趨勢、MNM的見解)

  • 簡介
  • EUROFINS SCIENTIFIC SE
  • SGS
  • CHARLES RIVER LABORATORIES INTERNATIONAL INC.
  • WUXI PHARMATECH (CAYMAN) INC.
  • PPD INC.
  • EXOVA GROUP PLC
  • PACE ANALYTICAL SERVICES INC.
  • INTERTEK GROUP PLC.
  • BIORELIANCE CORPORATION (MERCK KGAA)
  • SOURCE BIOSCIENCE
  • ENVIGO
  • ANABIOTEC
  • MEDISTRI SA

第13章 附錄

目錄
Product Code: AST 4341

The global healthcare analytical testing services market is estimated to grow at a CAGR of 11.3% from 2016 to 2021, to reach USD 4.13 billion by 2021 from USD 2.42 billion in 2016. Growth in this market is mainly attributed to the growing demand for analytical services for biologics and large-molecule drugs, increasing outsourcing of analytical testing by pharmaceutical companies, rising demand from the nutraceutical industry, and increasing acceptance of the QbD (Quality by Design) approach in pharmaceutical research/manufacturing. In addition, the high quality standards in the pharmaceutical industry, rapid growth in the biosimilars and biologics market, and presence of a large pool of analytical testing providers are further expected to drive the growth of this market. However, the pricing pressure faced by market players and shortage of skilled professionals in the healthcare analytical testing services industry may hinder the growth of this market to a certain extent during the forecast period.

In this report, the healthcare analytical testing services market is segmented on the basis of services, samples, end users, and regions. In 2015, the bioanalytical testing segment accounted for the largest share of the global healthcare analytical testing services market, by type. The large share of this segment can primarily be attributed to the large number of biologic molecules in the pipeline and the growing biopharmaceutical industry. On the basis of samples, the raw materials segment accounted for the largest share of the global healthcare analytical testing services market. In 2015, the pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the global healthcare analytical testing services market, by end user. This large share for pharmaceutical and biopharmaceutical companies is due to the increased R&D expenditure to develop new drug molecules, growing focus on delivering high-quality products, and rising demand for analytical testing by regulators.

Geographically, North America commanded a major share of the healthcare analytical testing services market in 2015. However, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Growth in the Asia-Pacific market can be attributed to the large pool of pharmaceutical and biopharmaceutical companies, government support from both an economic and policy standpoint to drive innovation in life sciences, and rapidly increasing demand for outsourcing of analytical testing.

Some of the prominent players in the healthcare analytical testing services market include Exova Group Plc. (U.K.), Eurofins Scientific SE (Luxembourg), SGS (Switzerland), PPD Inc. (U.S.), WuXi PharmaTech (Cayman) Inc. (China), Charles River Laboratories International Inc. (U.S.), Source BioScience Plc. (U.K.), Anabiotec (Belgium), Intertek Group Plc. (U.K.), Medistri SA (Switzerland), Pace Analytical Services Inc. (U.S.), and BioReliance Corporation (U.S.).

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering greater market shares. Firms purchasing the report could use any one or combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the service portfolios offered by the top players in the healthcare analytical testing services market. The report analyzes the healthcare analytical testing services market by service type, sample type, end user, and region
  • Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new services launches in the healthcare analytical testing services market
  • Market Development: Comprehensive information about the lucrative emerging markets by product and region
  • Market Diversification: Exhaustive information about new services, growing geographies, recent developments, and investments in the healthcare analytical testing services market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and services, and testing capabilities of leading players in the healthcare analytical testing services market

Table of Contents

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH APPROACH
    • 2.1.1. SECONDARY SOURCES
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY SOURCES
      • 2.1.2.1. Key data from primary sources
    • 2.1.3. KEY INDUSTRY INSIGHTS
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. MARKET SHARE ESTIMATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET OVERVIEW
  • 4.2. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER
  • 4.3. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: GEOGRAPHIC SNAPSHOT
  • 4.4. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: GEOGRAPHIC MIX
  • 4.5. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DEVELOPING VS. DEVELOPED COUNTRIES

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
    • 5.2.1. BY TYPE
    • 5.2.2. BY END USER
    • 5.2.3. BY SAMPLE
  • 5.3. MARKET DYNAMICS
  • 5.4. KEY MARKET DRIVERS
    • 5.4.1. GROWING DEMAND FOR ANALYTICAL SERVICES FOR BIOLOGICS AND LARGE-MOLECULE DRUGS
    • 5.4.2. INCREASING OUTSOURCING OF ANALYTICAL TESTING BY PHARMACEUTICAL COMPANIES
    • 5.4.3. RISING DEMAND FROM THE NUTRACEUTICAL INDUSTRY
    • 5.4.4. INCREASING ACCEPTANCE OF THE QBD APPROACH IN PHARMA RESEARCH/MANUFACTURING
  • 5.5. KEY MARKET RESTRAINTS
    • 5.5.1. PRICING PRESSURE FACED BY MAJOR PLAYERS
    • 5.5.2. SHORTAGE OF SKILLED PROFESSIONALS
  • 5.6. KEY MARKET OPPORTUNITY
    • 5.6.1. RISING DEMAND FOR SPECIALIZED ANALYTICAL TESTING SERVICES
  • 5.7. KEY CHALLENGES
    • 5.7.1. INNOVATIVE FORMULATIONS AND MEDICAL DEVICES DEMANDING A UNIQUE ANALYTICAL TESTING APPROACH
    • 5.7.2. DEVELOPMENT OF APPROPRIATE DISSOLUTION METHODS
    • 5.7.3. NEED TO IMPROVE THE SENSITIVITY OF ANALYTICAL METHODS TO DETECT DEGRADATION PRODUCTS AND ABILITY TO SEPARATE KNOWN IMPURITIES

6. INDUSTRY INSIGHTS

  • 6.1. INDUSTRY TRENDS
    • 6.1.1. GROWING CONSOLIDATION IN THE HEALTHCARE ANALYTICAL TESTING SERVICES INDUSTRY
    • 6.1.2. OUTSOURCING OF ANALYTICAL SERVICES AND PREFERRED-VENDOR PARTNERSHIPS
      • 6.1.2.1. Preferred-vendor Partnerships
  • 6.2. REGULATORY ANALYSIS

7. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE

  • 7.1. INTRODUCTION
  • 7.2. BIOANALYTICAL TESTING SERVICES
    • 7.2.1. CELL-BASED ASSAYS
    • 7.2.2. VIROLOGY TESTING
      • 7.2.2.1. In Vitro Assays
      • 7.2.2.2. In Vivo Assays
      • 7.2.2.3. Species-specific Viral PCR Assays
    • 7.2.3. METHOD DEVELOPMENT OPTIMIZATION AND VALIDATION
    • 7.2.4. IMMUNOGENICITY AND NEUTRALIZING ANTIBODY TESTING
    • 7.2.5. BIOMARKER TESTING
    • 7.2.6. PHARMACOKINETIC TESTING
    • 7.2.7. METABOLITE PROFILING AND MASS BALANCE STUDIES
  • 7.3. PHYSICAL CHARACTERIZATION SERVICES
    • 7.3.1. LASER PARTICLE SIZE ANALYSIS
    • 7.3.2. THERMAL ANALYSIS
    • 7.3.3. IMAGE ANALYSIS
    • 7.3.4. SURFACE AREA ANALYSIS
    • 7.3.5. OTHER PHYSICAL CHARACTERIZATION SERVICES
  • 7.4. METHOD VALIDATION
    • 7.4.1. EXTRACTABLES & LEACHABLES METHOD DEVELOPMENT AND VALIDATION
    • 7.4.2. PROCESS IMPURITY METHOD DEVELOPMENT AND VALIDATION
    • 7.4.3. CLEANING VALIDATION METHOD DEVELOPMENT
    • 7.4.4. ANALYTICAL STANDARD CHARACTERIZATION
    • 7.4.5. PEAK IDENTIFICATION
    • 7.4.6. TECHNICAL CONSULTING
    • 7.4.7. OTHER METHOD VALIDATION SERVICES
  • 7.5. RAW MATERIAL TESTING
    • 7.5.1. COMPLETE COMPENDIAL TESTING
    • 7.5.2. HEAVY METAL TESTING
    • 7.5.3. CONTAINER TESTING
    • 7.5.4. KARL FISCHER ANALYSIS
    • 7.5.5. WET CHEMISTRY ANALYSIS
    • 7.5.6. OTHER RAW MATERIAL TESTING SERVICES
  • 7.6. BATCH RELEASE TESTING SERVICES
    • 7.6.1. DISSOLUTION TESTING
    • 7.6.2. PHYSICAL TESTS
    • 7.6.3. ELEMENTAL IMPURITY TESTING
    • 7.6.4. DISINTEGRATION TESTING
    • 7.6.5. HARDNESS TESTING
    • 7.6.6. FRIABILITY TESTING
    • 7.6.7. OTHER BATCH RELEASE TESTING SERVICES
  • 7.7. STABILITY TESTING
    • 7.7.1. DRUG SUBSTANCE STABILITY TESTING
    • 7.7.2. FORMULATION EVALUATION STABILITY TESTING
    • 7.7.3. STABILITY INDICATING METHOD VALIDATION
    • 7.7.4. ACCELERATED STABILITY TESTING
    • 7.7.5. PHOTOSTABILITY TESTING
    • 7.7.6. COMPARATIVE STABILITY TESTING
    • 7.7.7. OTHER STABILITY TESTING SERVICES
  • 7.8. MICROBIAL TESTING
    • 7.8.1. MICROBIAL LIMIT TESTING
    • 7.8.2. STERILITY TESTING
    • 7.8.3. ENDOTOXIN TESTING
    • 7.8.4. PRESERVATIVE EFFICACY TESTING
    • 7.8.5. WATER TESTING
    • 7.8.6. OTHER MICROBIAL TESTING SERVICES
  • 7.9. ENVIRONMENTAL MONITORING
    • 7.9.1. AIR TESTING
    • 7.9.2. WASTEWATER/ETP TESTING
    • 7.9.3. OTHER ENVIRONMENTAL MONITORING SERVICES

8. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY SAMPLE

  • 8.1. INTRODUCTION
  • 8.2. RAW MATERIALS
  • 8.3. FINISHED PRODUCTS
  • 8.4. IN-PROCESS SAMPLES
  • 8.5. ENVIRONMENTAL SAMPLES

9. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
  • 9.3. MEDICAL DEVICE COMPANIES
  • 9.4. CONTRACT RESEARCH ORGANIZATIONS

10. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. GERMANY
    • 10.3.2. U.K.
    • 10.3.3. FRANCE
    • 10.3.4. ITALY
    • 10.3.5. SPAIN
    • 10.3.6. REST OF EUROPE
  • 10.4. ASIA-PACIFIC (APAC)
    • 10.4.1. CHINA
    • 10.4.2. JAPAN
    • 10.4.3. INDIA
    • 10.4.4. REST OF APAC
  • 10.5. REST OF THE WORLD (ROW)
    • 10.5.1. LATIN AMERICA
    • 10.5.2. MIDDLE EAST AND AFRICA

11. COMPETITIVE LANDSCAPE

  • 11.1. INTRODUCTION
  • 11.2. MARKET SHARE ANALYSIS
  • 11.3. COMPETITIVE SITUATION AND TRENDS
    • 11.3.1. ACQUISITIONS
    • 11.3.2. EXPANSIONS
    • 11.3.3. AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
    • 11.3.4. SERVICE LAUNCHES

12. COMPANY PROFILES (Business Overview, Products & Services, Developments, MnM View)*

  • 12.1. INTRODUCTION
  • 12.2. EUROFINS SCIENTIFIC SE
  • 12.3. SGS
  • 12.4. CHARLES RIVER LABORATORIES INTERNATIONAL INC.
  • 12.5. WUXI PHARMATECH (CAYMAN) INC.
  • 12.6. PPD INC.
  • 12.7. EXOVA GROUP PLC
  • 12.8. PACE ANALYTICAL SERVICES INC.
  • 12.9. INTERTEK GROUP PLC.
  • 12.1. BIORELIANCE CORPORATION (MERCK KGAA)
  • 12.11. SOURCE BIOSCIENCE
  • 12.12. ENVIGO
  • 12.13. ANABIOTEC
  • 12.14. MEDISTRI SA

*Details on MarketsandMarkets view, Introduction, Product & Services, New Developments might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. INSIGHTS OF INDUSTRY EXPERTS
  • 13.2. OTHER DEVELOPMENTS
  • 13.3. DISCUSSION GUIDE
  • 13.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: BUSINESS EXPENDITURE ON R&D (BERD) IN THE PHARMACEUTICAL INDUSTRY AS A PROPORTION OF GDP AND TOTAL BERD (2011)
  • TABLE 2: ACTIVITIES OUTSOURCED IN THE PHARMACEUTICAL INDUSTRY (2014 VS. 2015)
  • TABLE 3: REGULATORY DOCUMENTS INTRODUCING AND DEFINING THE QBD PARADIGM
  • TABLE 4: GROWTH IN THE BIOLOGICS MARKET, RISING DEMAND FOR COST-EFFECTIVE DRUG DEVELOPMENT, AND INCREASING ACCEPTANCE OF THE QBD APPROACH TO DRIVE MARKET GROWTH
  • TABLE 5: PRICING PRESSURE FACED BY MAJOR PLAYERS AND SHORTAGE OF SKILLED PROFESSIONALS ARE RESTRAINING MARKET GROWTH
  • TABLE 6: RISING DEMAND FOR SPECIALIZED ANALYTICAL TESTING SERVICES PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES
  • TABLE 7: SELECTED PUBLICATIONS AND GUIDELINES FOR THE CONTROL OF PHARMACEUTICAL IMPURITIES
  • TABLE 8: INNOVATIVE FORMULATIONS AND MEDICAL DEVICES DEMANDING A UNIQUE ANALYTICAL TESTING APPROACH AND THE DEVELOPMENT OF APPROPRIATE DISSOLUTION METHODS ARE MAJOR MARKET CHALLENGES
  • TABLE 9: MAJOR ACQUISITIONS IN HEALTHCARE ANALYTICAL TESTING SERVICES INDUSTRY (2013--2016)
  • TABLE 10: ACTIVITIES OUTSOURCED IN PHARMACEUTICAL INDUSTRY (2015)
  • TABLE 11: GLP REQUIREMENT FOR STUDIES
  • TABLE 12: DEVELOPMENT OF GLP ACROSS COUNTRIES
  • TABLE 13: OVERVIEW OF GUIDELINES OF LABORATORY SERVICES
  • TABLE 14: SUMMARY OF GLP REGULATION (FDA)
  • TABLE 15: REGULATORY AUTHORITIES AND LAUNCH OF GLP MONITORING PROGRAMS IN EUROPEAN COUNTRIES
  • TABLE 16: GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 17: GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 18: GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 19: GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 20: GLOBAL CELL-BASED ASSAY SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 21: GLOBAL VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 22: GLOBAL VIROLOGY TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 23: GLOBAL IN VITRO ASSAY SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 24: GLOBAL IN VIVO ASSAY SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 25: GLOBAL SPECIES-SPECIFIC VIRAL PCR ASSAY SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 26: METHOD VALIDATION CHARACTERISTICS FOR BIOPHARMACEUTICALS (AS PER ICH Q2A AND Q2B )
  • TABLE 27: GLOBAL METHOD DEVELOPMENT OPTIMIZATION AND VALIDATION SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 28: GLOBAL IMMUNOGENICITY AND NEUTRALIZING ANTIBODY TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 29: GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 30: GLOBAL PHARMACOKINETIC TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 31: GLOBAL METABOLITE PROFILING AND MASS BALANCE STUDIES SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 32: GLOBAL PHYSICAL CHARACTERIZATION SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 33: GLOBAL PHYSICAL CHARACTERIZATION MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 34: GLOBAL LASER PARTICLE SIZE ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 35: GLOBAL THERMAL ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 36: GLOBAL IMAGE ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 37: GLOBAL SURFACE AREA ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 38: GLOBAL OTHER PHYSICAL CHARACTERIZATION SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 39: GLOBAL METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 40: GLOBAL METHOD VALIDATION SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 41: GLOBAL EXTRACTABLES & LEACHABLES METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 42: GLOBAL PROCESS IMPURITY METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 43: GLOBAL CLEANING VALIDATION METHOD DEVELOPMENT SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 44: GLOBAL ANALYTICAL STANDARD CHARACTERIZATION SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 45: GLOBAL PEAK IDENTIFICATION SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 46: GLOBAL TECHNICAL CONSULTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 47: GLOBAL OTHER METHOD VALIDATION SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 48: GLOBAL RAW MATERIAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 49: GLOBAL RAW MATERIAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 50: GLOBAL COMPLETE COMPENDIAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 51: GLOBAL HEAVY METAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 52: CHARACTERISTICS OF MAJOR CCI TESTING METHODS
  • TABLE 53: GLOBAL CONTAINER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 54: GLOBAL KARL FISCHER ANALYTICAL TESTING MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 55: GLOBAL WET CHEMISTRY ANALYSIS MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 56: GLOBAL OTHER RAW MATERIAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 57: GLOBAL BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 58: GLOBAL BATCH RELEASES TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 59: EVOLUTION OF FDA GUIDELINES FOR DISSOLUTION TESTING
  • TABLE 60: GLOBAL DISSOLUTION TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 61: GLOBAL PHYSICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 62: ICH PERMITTED DAILY EXPOSURE FOR ELEMENTAL IMPURITIES
  • TABLE 63: GLOBAL ELEMENTAL IMPURITY TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 64: USP 32 DISINTEGRATION METHOD AND IMMERSION MEDIA INFORMATION
  • TABLE 65: GLOBAL DISINTEGRATION TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 66: GLOBAL HARDNESS TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 67: GLOBAL FRIABILITY TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 68: GLOBAL OTHER BATCH RELEASE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 69: CODES AND TITLES OF ICH STABILITY GUIDELINES
  • TABLE 70: GUIDELINES DERIVED FROM INTERNATIONAL CONFERENCE ON HARMONISATION Q1A (R2)
  • TABLE 71: GLOBAL STABILITY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 72: GLOBAL STABILITY TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 73: GLOBAL DRUG SUBSTANCE STABILITY TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 74: ICH GUIDELINE CODES FOR FORMULATION EVALUATION STABILITY TESTING SERVICES
  • TABLE 75: GLOBAL FORMULATION EVALUATION STABILITY TESTING MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 76: GLOBAL STABILITY INDICATING METHOD VALIDATION SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 77: ACCELERATED STABILITY STUDY CONDITION
  • TABLE 78: GLOBAL ACCELERATED STABILITY TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 79: PHARMACEUTICAL PRODUCT CLASS BASED ON PHOTOSENSITIVITY TESTING
  • TABLE 80: GLOBAL PHOTOSTABILITY TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 81: GLOBAL COMPARATIVE STABILITY TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 82: GLOBAL OTHER STABILITY TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 83: GLOBAL MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 84: GLOBAL MICROBIAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 85: STANDARD LIMIT FOR MICROBIAL LIMIT TESTING
  • TABLE 86: GLOBAL MICROBIAL LIMIT TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 87: GLOBAL STERILITY TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 88: GLOBAL ENDOTOXIN TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 89: GLOBAL PRESERVATIVE EFFICACY TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 90: STANDARDIZED LIMITS FOR WATER TESTING
  • TABLE 91: GLOBAL WATER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 92: GLOBAL OTHER MICROBIAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 93: GLOBAL ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 94: GLOBAL ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 95: CLEANROOM CLASSIFICATION
  • TABLE 96: LIMITS FOR PARTICULATE CONTAMINATION
  • TABLE 97: GLOBAL AIR TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 98: STANDARDS FOR WASTE WATER QUALITY
  • TABLE 99: GLOBAL WASTEWATER/ETP TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 100: GLOBAL OTHER ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 101: GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE, 2014--2021 (USD MILLION)
  • TABLE 102: GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE FOR RAW MATERIALS, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 103: GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE FOR FINISHED PRODUCTS, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 104: GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE FOR IN-PROCESS SAMPLES, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 105: GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE FOR ENVIRONMENTAL SAMPLES, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 106: GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2014--2021 (USD MILLION)
  • TABLE 107: NUMBER OF DRUGS IN DEVELOPMENT ACROSS THE GLOBE,
  • TABLE 108: GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 109: COVERAGE WITH EVIDENCE DEVELOPMENT (CED) SCHEMES IN GERMANY, FRANCE, AND U.K.
  • TABLE 110: GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 111: GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 112: GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 113: NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 114: NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 115: NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 116: NORTH AMERICA: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 117: NORTH AMERICA: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 118: NORTH AMERICA: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 119: NORTH AMERICA: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 120: NORTH AMERICA: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 121: NORTH AMERICA: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 122: NORTH AMERICA: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 123: NORTH AMERICA: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 124: NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE, 2014-2021 (USD MILLION)
  • TABLE 125: NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2014--2021 (USD MILLION)
  • TABLE 126: MAJOR BIOLOGICS PATENT EXPIRIES IN THE U.S.
  • TABLE 127: MAJOR STRATEGIC DEVELOPMENTS BY ANALYTICAL TESTING SERVICE PROVIDERS IN THE U.S.
  • TABLE 128: U.S.: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 129: U.S.: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 130: U.S.: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 131: U.S.: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 132: U.S.: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 133: U.S.: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 134: U.S.: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 135: U.S.: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 136: U.S.: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 137: U.S.: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 138: U.S.: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE, 2014-2021 (USD MILLION)
  • TABLE 139: U.S.: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2014--2021 (USD MILLION)
  • TABLE 140: CANADA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 141: CANADA: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 142: CANADA: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 143: CANADA: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 144: CANADA: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 145: CANADA: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 146: CANADA: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 147: CANADA: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 148: CANADA ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 149: CANADA: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 150: CANADA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE, 2014-2021 (USD MILLION)
  • TABLE 151: CANADA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2014--2021 (USD MILLION)
  • TABLE 152: EUROPE: PHARMACEUTICAL R&D EXPENDITURE AND PRODUCTION, BY COUNTRY (2012)
  • TABLE 153: MAJOR STRATEGIC DEVELOPMENTS BY ANALYTICAL TESTING SERVICE PROVIDERS IN EUROPE
  • TABLE 154: EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014--2021 (USD MILLION)
  • TABLE 155: EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 156: EUROPE: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 157: EUROPE: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 158: EUROPE: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 159: EUROPE: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 160: EUROPE: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 161: EUROPE: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 162: EUROPE: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 163: EUROPE: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 164: EUROPE: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 165: EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE, 2014-2021 (USD MILLION)
  • TABLE 166: EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2014--2021 (USD MILLION)
  • TABLE 167: PHARMACEUTICAL PRODUCTION IN GERMANY (2009-2013)
  • TABLE 168: BIOTECHNOLOGY INDUSTRY IN GERMANY (2009-2014)
  • TABLE 169: GERMANY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 170: GERMANY: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 171: GERMANY: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 172: GERMANY: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 173: GERMANY: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 174: GERMANY: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 175: GERMANY: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 176: GERMANY: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 177: GERMANY: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 178: GERMANY: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 179: GERMANY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE, 2014-2021 (USD MILLION)
  • TABLE 180: GERMANY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2014--2021 (USD MILLION)
  • TABLE 181: U.K.: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 182: U.K.: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 183: U.K.: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 184: U.K.: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 185: U.K.: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 186: U.K.: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 187: U.K.: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 188: U.K.: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 189: U.K.: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 190: U.K.: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 191: U.K.: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE, 2014--2021 (USD MILLION)
  • TABLE 192: U.K.: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2014--2021 (USD MILLION)
  • TABLE 193: FRANCE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 194: FRANCE: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 195: FRANCE: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 196: FRANCE: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 197: FRANCE: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 198: FRANCE: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 199: FRANCE: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 200: FRANCE: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 201: FRANCE: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 202: FRANCE: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 203: FRANCE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE, 2014--2021 (USD MILLION)
  • TABLE 204: FRANCE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2014--2021 (USD MILLION)
  • TABLE 205: CLINICAL TRIALS PER DRUG TYPOLOGY (2013 VS. 2014)
  • TABLE 206: CLINICAL TRIALS PER OUTCOME (2013 VS. 2014)
  • TABLE 207: ITALY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 208: ITALY: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 209: ITALY: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 210: ITALY: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 211: ITALY: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 212: ITALY: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 213: ITALY: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 214: ITALY: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 215: ITALY: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 216: ITALY: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 217: ITALY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE, 2014-2021 (USD MILLION)
  • TABLE 218: ITALY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2014--2021 (USD MILLION)
  • TABLE 219: SPAIN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 220: SPAIN: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 221: SPAIN: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 222: SPAIN: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 223: SPAIN: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 224: SPAIN: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 225: SPAIN: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 226: SPAIN: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 227: SPAIN: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 228: SPAIN: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 229: SPAIN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE, 2014-2021, (USD MILLION)
  • TABLE 230: SPAIN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2014--2021 (USD MILLION)
  • TABLE 231: PHARMACEUTICAL PRODUCTION AND R&D EXPENDITURE IN DENMARK (2012 VS 2013)
  • TABLE 232: ROE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 233: ROE: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 234: ROE: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 235: ROE: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 236: ROE: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 237: ROE: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 238: ROE: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 239: ROE: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 240: ROE: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 241: ROE: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 242: ROE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE, 2014-2021 (USD MILLION)
  • TABLE 243: ROE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2014--2021 (USD MILLION)
  • TABLE 244: ASIA-PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 245: ASIA-PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 246: ASIA-PACIFIC: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 247: ASIA-PACIFIC: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 248: ASIA-PACIFIC: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 249: ASIA-PACIFIC: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 250: ASIA-PACIFIC: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 251: ASIA-PACIFIC: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 252: ASIA-PACIFIC: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 253: ASIA-PACIFIC: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 254: ASIA-PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE, 2014--2021 (USD MILLION)
  • TABLE 255: ASIA-PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2014--2021 (USD MILLION)
  • TABLE 256: COST OF CLINICAL TRIALS: U.S. AND CHINA (2012)
  • TABLE 257: CHINA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 258: CHINA: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 259: CHINA: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 260: CHINA: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 261: CHINA: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 262: CHINA: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 263: CHINA: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 264: CHINA: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 265: CHINA: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 266: CHINA: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 267: CHINA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE, 2014--2021 (USD MILLION)
  • TABLE 268: CHINA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2014--2021 (USD MILLION)
  • TABLE 269: JAPAN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 270: JAPAN: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 271: JAPAN: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 272: JAPAN: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 273: JAPAN: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 274: JAPAN: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 275: JAPAN: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 276: JAPAN: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 277: JAPAN: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 278: JAPAN: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 279: JAPAN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE, 2014--2021 (USD MILLION)
  • TABLE 280: JAPAN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2014--2021 (USD MILLION)
  • TABLE 281: INDIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 282: INDIA: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 283: INDIA: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 284: INDIA: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 285: INDIA: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 286: INDIA: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 287: INDIA: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 288: INDIA: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 289: INDIA: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 290: INDIA: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 291: INDIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE, 2014--2021 (USD MILLION)
  • TABLE 292: INDIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2014--2021 (USD MILLION)
  • TABLE 293: REST OF APAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 294: REST OF APAC: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 295: REST OF APAC: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 296: REST OF APAC: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 297: REST OF APAC: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 298: REST OF APAC: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 299: REST OF APAC: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 300: REST OF APAC: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 301: REST OF APAC: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 302: REST OF APAC: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 303: REST OF APAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE, 2014--2021 (USD MILLION)
  • TABLE 304: REST OF APAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2014--2021 (USD MILLION)
  • TABLE 305: ROW: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 306: ROW: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 307: ROW: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 308: ROW: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 309: ROW: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 310: ROW: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 311: ROW: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 312: ROW: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 313: ROW: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 314: ROW: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 315: ROW: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE, 2014--2021 (USD MILLION)
  • TABLE 316: ROW: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2014--2021 (USD MILLION)
  • TABLE 317: GROSS EXPENDITURE ON R&D IN MAJOR LATIN AMERICAN COUNTRIES
  • TABLE 318: LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 319: LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 320: LATIN AMERICA: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 321: LATIN AMERICA: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 322: LATIN AMERICA: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 323: LATIN AMERICA: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 324: LATIN AMERICA: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 325: LATIN AMERICA: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 326: LATIN AMERICA: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 327: LATIN AMERICA: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 328: LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE, 2014--2021 (USD MILLION)
  • TABLE 329: LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2014--2021 (USD MILLION)
  • TABLE 330: MIDDLE EAST AND AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 331: MIDDLE EAST AND AFRICA: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 332: MIDDLE EAST AND AFRICA: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 333: MIDDLE EAST AND AFRICA: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 334: MIDDLE EAST AND AFRICA: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 335: MIDDLE EAST AND AFRICA: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 336: MIDDLE EAST AND AFRICA: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 337: MIDDLE EAST AND AFRICA: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 338: MIDDLE EAST AND AFRICA: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 339: MIDDLE EAST AND AFRICA: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE, 2014--2021 (USD MILLION)
  • TABLE 340: MIDDLE EAST AND AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE, 2014--2021 (USD MILLION)
  • TABLE 341: MIDDLE EAST AND AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2014--2021 (USD MILLION)
  • TABLE 342: GROWTH STRATEGY MATRIX
  • TABLE 343: ACQUISITIONS, 2013--2016
  • TABLE 344: EXPANSIONS, 2013--2016
  • TABLE 345: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2013--2016
  • TABLE 346: SERVICE LAUNCHES, 2013--2016

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: BOTTOM-UP APPROACH
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: BIOANALYTICAL TESTING SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 7: ELEMENTAL IMPURITY TESTING SEGMENT EXPECTED TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 8: GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY SAMPLE TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 9: PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES WILL CONTINUE TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 10: GEOGRAPHIC SNAPSHOT: GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
  • FIGURE 11: GROWING DEMAND FOR ANALYTICAL SERVICES FOR BIOLOGICS AND LARGE MOLECULE DRUGS TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 12: PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES COMMANDED THE LARGEST SHARE OF THE APAC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET IN 2015
  • FIGURE 13: U.S. DOMINATED THE GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET IN 2015
  • FIGURE 14: NORTH AMERICA TO DOMINATE THE GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 15: CHINA TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 16: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SEGMENTATION, BY TYPE 49
  • FIGURE 17: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SEGMENTATION, BY END USER 50
  • FIGURE 18: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SEGMENTATION, BY SAMPLE 50
  • FIGURE 19: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 20: TRADITIONAL AND AQBD APPROACHES FOR ANALYTICAL METHOD DEVELOPMENT
  • FIGURE 21: GROWING CONSOLIDATION IN THE ANALYTICAL TESTING SERVICES INDUSTRY AND OUTSOURCING OF ANALYTICAL TESTING SERVICES ARE LEADING INDUSTRY TRENDS
  • FIGURE 22: TACTICAL OUTSOURCING VS STRATEGIC OUTSOURCING (2014)
  • FIGURE 23: CELL-BASED ASSAYS WILL CONTINUE TO DOMINATE THE BIOANALYTICAL TESTING SERVICES MARKET DURING FORECAST PERIOD
  • FIGURE 24: LASER PARTICLE SIZE ANALYSIS WILL CONITINUE TO DOMINATE THE PHYSICAL CHARACTERIZATION SERVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 25: EXTRACTABLES AND LEACHABLES METHOD DEVELOPMENT AND VALIDATION PROCESS
  • FIGURE 26: STABILITY STUDIES AT DIFFERENT PHASES OF DRUG DEVELOPMENT
  • FIGURE 27: STABILITY INDICATING METHOD VALIDATION SERVICES IN THE PHARMACEUTICAL INDUSTRY
  • FIGURE 28: PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO DOMINATE THE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
  • FIGURE 29: R&D SPENDING OF PHRMA MEMBER COMPANIES, 1980-2014
  • FIGURE 30: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET GROWTH RATE, BY COUNTRY/REGION (2016--2021) 169
  • FIGURE 31: NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SNAPSHOT
  • FIGURE 32: PHARMACEUTICAL R&D EXPENDITURE IN THE U.S. (1990--2013)
  • FIGURE 33: NEW MOLECULAR ENTITY AND NEW BIOLOGIC LICENSE APPLICATION APPROVALS
  • FIGURE 34: PHARMACEUTICAL R&D EXPENDITURE IN EUROPE (2010 VS. 2013)
  • FIGURE 35: NUMBER OF NEW CHEMICAL OR BIOLOGICAL ENTITIES IN EUROPE (2004--2013)
  • FIGURE 36: ASIA-PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SNAPSHOT
  • FIGURE 37: ACQUISITIONS--KEY GROWTH STRATEGY PURSUED BY PLAYERS IN THE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FROM 2013 TO 2016
  • FIGURE 38: GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
  • FIGURE 39: BATTLE FOR MARKET SHARE: ACQUISITIONS IS THE KEY GROWTH STRATEGY
  • FIGURE 40: GEOGRAPHICAL REVENUE MIX OF THE TOP 4 PLAYERS
  • FIGURE 41: COMPANY SNAPSHOT: EUROFINS SCIENTIFIC SE
  • FIGURE 42: COMPANY SNAPSHOT: SGS
  • FIGURE 43: COMPANY SNAPSHOT: CHARLES RIVER LABORATORIES INTERNATIONAL INC.
  • FIGURE 44: COMPANY SNAPSHOT: WUXI PHARMATECH (CAYMAN) INC.
  • FIGURE 45: COMPANY SNAPSHOT: EXOVA GROUP PLC
  • FIGURE 46: COMPANY SNAPSHOT: INTERTEK GROUP PLC.
  • FIGURE 47: COMPANY SNAPSHOT: BIORELIANCE CORPORATION
  • FIGURE 48: COMPANY SNAPSHOT: SOURCE BIOSCIENCE
Back to Top